Uriu K, Kaizu K, Abe R, Oda S, Chiba S, Eto S, Suzuki H
J UOEH. 1984 Dec 1;6(4):391-6. doi: 10.7888/juoeh.6.391.
A 54-year-old female was admitted to our hospital in November 1979 with a history of lumbago and proteinuria. She was diagnosed as suffering from chronic renal failure (CRF) due to multiple myeloma (Bence-Jones kappa type). Intermittent COP therapy (a combination of cyclophosphamide, vincristine and prednisolone) and peritoneal dialysis were started. Her clinical condition was improved and well controlled by peritoneal dialysis over a period of 26 months until she died of pneumonia. Renal failure due to multiple myeloma has been a very poor prognosis. Hemodialysis has been used for renal failure much more frequently than peritoneal dialysis. In this case, control of chronic renal failure due to multiple myeloma with peritoneal dialysis was successfully performed over a long period of time. Peritoneal dialysis, therefore, may be an effective therapy for CRF due to multiple myeloma.
一名54岁女性于1979年11月因腰痛和蛋白尿入住我院。她被诊断为患有由多发性骨髓瘤(本斯-琼斯κ型)引起的慢性肾衰竭(CRF)。开始进行间歇性COP疗法(环磷酰胺、长春新碱和泼尼松龙联合使用)及腹膜透析。她的临床状况得到改善,并通过腹膜透析在26个月的时间里得到良好控制,直至死于肺炎。由多发性骨髓瘤导致的肾衰竭预后一直很差。血液透析用于肾衰竭的频率比腹膜透析高得多。在本病例中,通过腹膜透析成功地长期控制了由多发性骨髓瘤引起的慢性肾衰竭。因此,腹膜透析可能是治疗由多发性骨髓瘤导致的CRF的一种有效疗法。